NCT00693953

Withdrawn

Using the Digital EEG Spectral Analysis in Assessing Neuroel...

Yellen & Associates, Inc.Source

Compare

Other study identifiers

Sponsor study identifier

PA-06-278

Study Type

observational

Estimated enrollment

200

Locations

1 country

Sites

1

Timeline

Study Start

January 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

January 2011

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

December 2012

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

Individuals with Autism Spectrum Disorder will have abnormal DESA® results. Our objective is to use neuroelectrical measures to determine the degree of processing abnormalities in individuals with Autism. The study will survey processing patterns and will locate and evaluate the degree(s) of abnormalities for further study. The abnormal results of comprehensive neuroelectrical evaluations of individuals with Autism when compared to the normative database will provide objective, verifiable, neurophysiological information with which to form novel approaches to the disorder.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: withdrawn
Estimated enrollment: 200 participants
Study completion date: December 2012
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
June 5, 2008
Actual (reported)
First Posted
June 9, 2008
Actual (reported)
Study Start
January 2010
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
January 2011
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2012
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: October 2, 2009
Status Verified: October 2009
Last Update Submitted: October 1, 2009

Conditions

Asperger Syndrome Autism, Early Infantile Autism, Infantile Autistic Disorder

Keywords

Evoked PotentialsEvoked Potentials, AuditoryEvoked Potentials, VisualElectroencephalographyBrain Mapping

Study Arms (2)

1

Year one

2

Year two

Eligibility Criteria

Age5 Years - 25 Years

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64)

Sampling MethodNon-Probability Sample

Study Population

The study population includes individuals with Autism without exclusion on the basis of sex, gender, race or ethnicity. There will be 100 research subjects, with a ratio of four males to one female, and those being approximately sixty-five children and thirty-five adults.

You may qualify if:

The study will include children between the ages of five and eighteen, adults from the age of nineteen to twenty-five, and those with the diagnosis of Autism and Autism Spectrum Disorders.

Sponsors & Collaborators

Yellen & Associates, Inc.
Otherlead

Study Sites (1)

Yellen & Associates, Inc.

Northridge, California, 91326, United States

MeSH Terms

Conditions

Autistic DisorderAsperger Syndrome

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

Andrew G Yellen, PhD
President, Yellen & Associates, Inc.
PRINCIPAL INVESTIGATOR
Thomas Schweller, MD
Neurologist
STUDY CHAIR

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Sponsor Type: OTHER

Study Record Dates

First Submitted

June 5, 2008

First Posted

June 9, 2008

Study Start

January 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

January 2011

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

NCT01078844

Memantine in Adult Autism Spectrum Disorder

Not ApplicableTerminated

NCT00965068

Cholesterol in ASD: Characterization and Treatment

Phase 1/2Completed

NCT01086475

D-Cycloserine and Social Skills Training in Autism Spectrum Disorders

Phase 3Completed

NCT01983189

Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism

Phase 2Terminated

NCT00453180

A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders

Phase 2Completed

NCT00619190

Study of Aripiprazole to Treat Children and Adolescents With Autism

Phase 2Completed

You may not qualify if:

those with mental retardation
those with any other neurological disorder
those that cannot sit in a chair for one hundred and fifty minutes
those that have been previously diagnosed with a seizure disorder
those who are blind and/or deaf
those who are not ambulatory
those who cannot understand English
those that are not a resident of Los Angeles County

Contact the study team to confirm eligibility.

Study Completion

December 2012

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

October 2, 2009

Record last verified: 2009-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00693953
Data provider: ClinicalTrials.gov
Source updated: 2009-10-02
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:50 UTC

Locations

US(1)

Study Stopped

Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Study Arms (2)

1

2

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Study Arms (2)

1

2

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations